Norlase® LION® - Laser Indirect Ophthalmoscope

Redefining Laser Photocoagulator Treatment

Redefining Laser Photocoagulator Treatment

Key Features:
A selection of main features for this new Slit Lamp are listed below.
Topographic outcomes
Maps:
Indices:
Could the answer to more effective Dry Eye management already be sitting on the ocular surface?
Explore how tear film biomarkers are helping clinicians better understand the underlying drivers of Dry Eye Disease and support more personalised treatment decisions. Featuring Prof James Wolffsohn and Connan Tam, this webinar combines the latest science with practical clinical case studies.
The Lymphotoxin-α Test Kit (LTA-POC) is a rapid immunoassay test for in vitro quantitative detection of LTA protein in human tear samples. LTA-POC is intended for monitoring ocular surface immune homeostasis and facilitating clinical diagnosis of dry eye disease, as well as aiding in patient stratification and treatment selection. Used with Seinda’s i-ImmunDxTM Analyzer, LTA-POC aids rapid, accurate diagnosis at the patient’s side.
Why Choose Rexon-Eye®?
The MMP-9 Point-of-Care (POC) Test Kit offers a rapid, precise, and non-invasive method to support the diagnosis and personalised treatment of Dry Eye Disease (DED).
Built on Seinda’s patented technology, this test quantifies tear MMP-9 levels - an established biomarker of inflammation - within 15 minutes.
Why Test for MMP-9?
The IgE Tear Test Ki a breakthrough in point-of-care diagnostics for ocular allergy: Designed to support the diagnosis of allergic conjunctivitis and distinguish it from dry eye and other ocular conditions, the test provides objective, quantifiable data within 10 minutes using a simple 4-step method.
Why Choose Tear IgE?